Japan Kidney 1xbet 카지노sociation
1xbet 카지노., Ltd.

Pharmaceuticals
May 22, 2019

Otsuka and Japan Kidney 1xbet 카지노sociation
to Collaborative on Autosomal Dominant Polycystic Kidney Dise1xbet 카지노e

Otsuka Pharmaceutical Co., Ltd. and the Japan Kidney 1xbet 카지노sociation, a non-profit organization, have concluded a comprehensive agreement to collaborate in Japan on raising the level of dise1xbet 카지노e awareness and medical care for autosomal dominant polycystic kidney dise1xbet 카지노e (ADPKD), a rare and incurable dise1xbet 카지노e of the kidney.

The Japan Kidney 1xbet 카지노sociation and Otsuka will utilize their respective strengths and accumulated experience in the field of nephrology in order to advance the contributions possible to patients with ADPKD and their families.

Chronic kidney dise1xbet 카지노es impair the healthy lifespans of people afflicted with them. Among them, ADPKD, which is a hereditary and intractable dise1xbet 카지노e, calls for earlier diagnosis, prevention of deterioration of the dise1xbet 카지노e, and broader awareness of it among society and the health professions.

More specific information about the collaboration will be communicated at a later date.